Overexpression of 5-HT2C receptors in forebrain leads to elevated anxiety and hypoactivity

European Journal of Neuroscience

Volumn 30, Issue 2, 2009, Pages 299-306

  Kimura, Atsuko ^a   Stevenson, Paula L ^a   Carter, Roderick N ^a   MacColl, Gavin ^a   French, Karen L ^a   Paul Simons, J ^b   Al Shawi, Raya ^b   Kelly, Valerie ^a   Chapman, Karen E ^a   Holmes, Megan C ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

5 HT2C receptor; Anxiety; Behaviour; Transgenic mice

Indexed keywords

SEROTONIN 2C RECEPTOR;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DISEASE MODEL; FOREBRAIN; HIPPOCAMPUS; HYPOKINESIA; HYPOTHALAMUS; LIGAND BINDING; LIMBIC CORTEX; MALE; MOOD DISORDER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR INTRINSIC ACTIVITY; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; ANIMAL; ANXIETY; BIOSYNTHESIS; C57BL MOUSE; CBA MOUSE; CELL STRAIN COS1; CERCOPITHECUS; COMPARATIVE STUDY; GENE EXPRESSION; GENETICS; METABOLISM; MOTOR ACTIVITY; PHYSIOLOGY; RAT;

ANIMALS; ANXIETY; CERCOPITHECUS AETHIOPS; COS CELLS; GENE EXPRESSION; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; MOTOR ACTIVITY; PROSENCEPHALON; RATS; RECEPTOR, SEROTONIN, 5-HT2C;

EID: 67651154609     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2009.06831.x     Document Type: Article

References (48)

1. Alves, S.H., Pinheiro, G., Motta, V., Landeira-Fernandez, J. Cruz, A.P. (2004) Anxiogenic effects in the rat elevated plus-maze of 5-HT(2C) agonists into ventral but not dorsal hippocampus. Behav. Pharmacol., 15, 37 43.
2. Barnes, N.M. Sharp, T. (1999) A review of central 5-HT receptors and their function. Neuropharmacology, 38, 1083 1152.
3. Berg, K.A., Navailles, S., Sanchez, T.A., Silva, Y.M., Wood, M.D., Spampinato, U. Clarke, W.P. (2006) Differential effects of 5-methyl-1-[[2-[(2- methyl-3-pyridyl)oxyl]-5-pyridyl]carbamoyl]-6-trifluoro methylindone (SB 243213) on 5-hydroxytryptamine(2C) receptor-mediated responses. J. Pharmacol. Exp. Ther., 319, 260 268.
4. Bhansali, P., Dunning, J., Singer, S.E., David, L. Schmauss, C. (2007) Early life stress alters adult serotonin 2C receptor pre-mRNA editing and expression of the alpha subunit of the heterotrimeric G-protein G q. J. Neurosci., 27, 1467 1473.
5. Burns, C.M., Chu, H., Rueter, S.M., Hutchinson, L.K., Canton, H., Sanders-Bush, E. Emeson, R.B. (1997) Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature, 387, 303 308.
6. Cornelio, A.M. Nunes-de-Souza, R.L. (2007) Anxiogenic-like effects of mCPP microinfusions into the amygdala (but not dorsal or ventral hippocampus) in mice exposed to elevated plus-maze. Behav. Brain Res., 178, 82 89.
7. Cremers, T.I., Rea, K., Bosker, F.J., Wikstrom, H.V., Hogg, S., Mork, A. Westerink, B.H. (2007) Augmentation of SSRI effects on serotonin by 5-HT2C antagonists: mechanistic studies. Neuropsychopharmacology, 32, 1550 1557.
8. Dalton, G.L., Lee, M.D., Kennett, G.A., Dourish, C.T. Clifton, P.G. (2004) mCPP-induced hyperactivity in 5-HT2C receptor mutant mice is mediated by activation of multiple 5-HT receptor subtypes. Neuropharmacology, 46, 663 671.
9. Damjanoska, K.J., Muma, N.A., Zhang, Y., D'Souza, D.N., Garcia, F., Carrasco, G.A., Kindel, G.H., Haskins, K.A., Shankaran, M., Petersen, B.R. Van De Kar, L.D. (2003) Neuroendocrine evidence that (S)-2-(chloro-5-fluoro-indol- l-yl)-1-methylethylamine fumarate (Ro 60-0175) is not a selective 5-hydroxytryptamine(2C) receptor agonist. J. Pharmacol. Exp. Ther., 304, 1209 1216.
10. De Deurwaerdere, P., Navailles, S., Berg, K.A., Clarke, W.P. Spampinato, U. (2004) Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens. J. Neurosci., 24, 3235 3241.
11. Dekeyne, A., Mannoury la Cour, C., Gobert, A., Brocco, M., Lejeune, F., Serres, F., Sharp, T., Daszuta, A., Soumier, A., Papp, M., Rivet, J.M., Flik, G., Cremers, T.I., Muller, O., Lavielle, G. Millan, M.J. (2008) S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models. Psychopharmacology (Berl), 199, 549 568.
12. Di Giovanni, G., De Deurwaerdere, P., Di Mascio, M., Di Matteo, V., Esposito, E. Spampinato, U. (1999) Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study. Neuroscience, 91, 587 597.
13. Di Matteo, V., Di Giovanni, G., Di Mascio, M. Esposito, E. (1999) SB 242 084, a selective serotonin(2C) receptor antagonist, increases dopaminergic transmission in the mesolimbic system. Neuropharmacology, 38, 1195 1205.
14. Di Matteo, V., Pierucci, M. Esposito, E. (2004) Selective stimulation of serotonin2c receptors blocks the enhancement of striatal and accumbal dopamine release induced by nicotine administration. J. Neurochem., 89, 418 429. (Pubitemid 38495990)
15. Dunlop, J., Marquis, K.L., Lim, H.K., Leung, L., Kao, J., Cheesman, C. Rosenzweig-Lipson, S. (2006) Pharmacological profile of the 5-HT(2C) receptor agonist WAY-163909; therapeutic potential in multiple indications. CNS Drug Rev, 12, 167 177.
16. Englander, M.T., Dulawa, S.C., Bhansali, P. Schmauss, C. (2005) How stress and fluoxetine modulate serotonin 2C receptor pre-mRNA editing. J. Neurosci., 25, 648 651.
17. Gobert, A., Rivet, J.M., Lejeune, F., Newman-Tancredi, A., Adhumeau-Auclair, A., Nicolas, J.P., Cistarelli, L., Melon, C. Millan, M.J. (2000) Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat. Synapse, 36, 205 221.
18. Gurevich, I., Englander, M.T., Adlersberg, M., Siegal, N.B. Schmauss, C. (2002a) Modulation of serotonin 2C receptor editing by sustained changes in serotonergic neurotransmission. J. Neurosci., 22, 10529 10532.
19. Gurevich, I., Tamir, H., Arango, V., Dwork, A.J., Mann, J.J. Schmauss, C. (2002b) Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims. Neuron, 34, 349 356.
20. Hackler, E.A., Turner, G.H., Gresch, P.J., Sengupta, S., Deutch, A.Y., Avison, M.J., Gore, J.C. Sanders-Bush, E. (2007) 5-Hydroxytryptamine2C receptor contribution to m-chlorophenylpiperazine and N-methyl-beta-carboline-3- carboxamide-induced anxiety-like behavior and limbic brain activation. J. Pharmacol. Exp. Ther., 320, 1023 1029.
21. Hayashi, A., Suzuki, M., Sasamata, M. Miyata, K. (2004) Thermogenic effect of YM348, a novel 5-HT2C-receptor agonist, in rats. J. Pharm. Pharmacol., 56, 1551 1556.
22. Heisler, L.K., Pronchuk, N., Nonogaki, K., Zhou, L., Raber, J., Tung, L., Yeo, G.S., O'Rahilly, S., Colmers, W.F., Elmquist, J.K. Tecott, L.H. (2007a) Serotonin activates the hypothalamic-pituitary-adrenal axis via serotonin 2C receptor stimulation. J. Neurosci., 27, 6956 6964.
23. Heisler, L.K., Zhou, L., Bajwa, P., Hsu, J. Tecott, L.H. (2007b) Serotonin 5-HT(2C) receptors regulate anxiety-like behavior. Genes Brain Behav., 6, 491 496.
24. Hewitt, K.N., Lee, M.D., Dourish, C.T. Clifton, P.G. (2002) Serotonin 2C receptor agonists and the behavioural satiety sequence in mice. Pharmacol. Biochem. Behav., 71, 691 700.
25. Higgins, G.A., Ouagazzal, A.M. Grottick, A.J. (2001) Influence of the 5-HT(2C) receptor antagonist SB242,084 on behaviour produced by the 5-HT(2) agonist Ro60-0175 and the indirect 5-HT agonist dexfenfluramine. Br. J. Pharmacol., 133, 459 466.
26. Holmes, M.C., French, K.L. Seckl, J.R. (1995) Modulation of serotonin and corticosteroid receptor gene expression in the rat hippocampus with circadian rhythm and stress. Mol. Brain Res., 28, 186 192.
27. 2C and corticosteroid receptor gene expression in the hippocampus with food restriction and glucocorticoids. J. Neurosci., 17, 4056 4065.
28. Holmes, M.C., Abrahamsen, C.T., French, K.L., Paterson, J.M., Mullins, J.J. Seckl, J.R. (2006) The mother or the fetus? 11beta-hydroxysteroid dehydrogenase type 2 null mice provide evidence for direct fetal programming of behavior by endogenous glucocorticoids. J. Neurosci., 26, 3840 3844.
29. Hurley, J.H., Bloem, L.J., Pavalko, F., Liu, J., Tian, M., Simon, J.R. Yu, L. (1999) Structure-function studies of the eighth hydrophobic domain of a serotonin receptor. J. Neurochem., 72, 413 421.
30. Invernizzi, R.W., Pierucci, M., Calcagno, E., Di Giovanni, G., Di Matteo, V., Benigno, A. Esposito, E. (2007) Selective activation of 5-HT(2C) receptors stimulates GABA-ergic function in the rat substantia nigra pars reticulata: a combined in vivo electrophysiological and neurochemical study. Neuroscience, 144, 1523 1535.
31. Jenck, F., Bos, M., Wichmann, J., Stadler, H., Martin, J.R. Moreau, J.L. (1998) The role of 5-HT2C receptors in affective disorders. Expert Opin Investig Drugs, 7, 1587 1599.
32. Kawahara, Y., Grimberg, A., Teegarden, S., Mombereau, C., Liu, S., Bale, T.L., Blendy, J.A. Nishikura, K. (2008) Dysregulated editing of serotonin 2C receptor mRNAs results in energy dissipation and loss of fat mass. J. Neurosci., 28, 12834 12844.
33. 1B receptors. Psychopharmacology, 96, 93 100.
34. 1C receptor antagonists. Eur. J. Pharmacol., 164, 445 454.
35. Kennett, G.A., Wood, M.D., Bright, F., Trail, B., Riley, G., Holland, V., Avenell, K.Y., Stean, T., Upton, N., Bromidge, S., Forbes, I.T., Brown, A.M., Middlemiss, D.N. Blackburn, T.P. (1997) SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist. Neuropharmacology, 36, 609 620.
36. Lam, D.D., Przydzial, M.J., Ridley, S.H., Yeo, G.S., Rochford, J.J., O'Rahilly, S. Heisler, L.K. (2008) Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors. Endocrinology, 149, 1323 1328.
37. Lee, M.D., Somerville, E.M., Kennett, G.A., Dourish, C.T. Clifton, P.G. (2004) Reduced hypophagic effects of d-fenfluramine and the 5-HT2C receptor agonist mCPP in 5-HT1B receptor knockout mice. Psychopharmacology (Berl), 176, 39 49.
38. Marazziti, D., Ori, M., Pasqualetti, M., Nardi, I. Cassano, G.B. (1999) Distribution of the 5-HT2C receptor mRNA in human brain. Biol. Psychiatry, 45, 209.
39. Martin, G.R. Humphrey, P.P. (1994) Receptors for 5-hydroxytryptamine: current perspectives on classification and nomenclature. Neuropharmacology, 33, 261 273.
40. Mayford, M., Bach, M.E., Huang, Y.Y., Wang, L., Hawkins, R.D. Kandel, E.R. (1996) Control of memory formation through regulated expression of a CaMKII transgene. Science, 274, 1678 1683.
41. Millan, M.J. (2005) Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies. Therapie, 60, 441 460.
42. Millan, M.J., Brocco, M., Gobert, A. Dekeyne, A. (2005) Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade. Psychopharmacology (Berl), 177, 448 458.
43. Niswender, C.M., Copeland, S.C., Herrick-Davis, K., Emeson, R.B. Sanders-Bush, E. (1999) RNA editing of the human serotonin 5-Hydroxytryptamine 2C receptor silences constitutive activity. J. Biol. Chem., 274, 9472 9478.
44. Nonogaki, K., Abdallah, L., Goulding, E.H., Bonasera, S.J. Tecott, L.H. (2003) Hyperactivity and reduced energy cost of physical activity in serotonin 5-HT(2C) receptor mutant mice. Diabetes, 52, 315 320.
45. Nonogaki, K., Nozue, K., Kuboki, T. Oka, Y. (2007) Milnacipran, a serotonin and norepinephrine reuptake inhibitor, induces appetite-suppressing effects without inducing hypothalamic stress responses in mice. Am. J. Physiol. Regul. Integr. Comp. Physiol., 292, R1775 1781.
46. Palacios, J., Waeber, C., Hoyer, D. Mengod, G. (1990) Distribution of serotonin receptors. Ann. N Y Acad. Sci., 600, 36 52.
47. Stiedl, O., Misane, I., Koch, M., Pattij, T., Meyer, M. Ogren, S.O. (2007) Activation of the brain 5-HT2C receptors causes hypolocomotion without anxiogenic-like cardiovascular adjustments in mice. Neuropharmacology, 52, 949 957.
48. 2C serotonin receptors. Nature, 374, 542 546.